Danaher Corp. (DHR)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Danaher Corp. (DHR)
Company Performance

Current Price

as of Dec 04, 2024

$236.26

P/E Ratio

45.06

Market Cap

$170.64B

Description

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Metrics

Overview

  • HQWashington, DC
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerDHR
  • Price$236.26-1.91%

Trading Information

  • Market cap$170.64B
  • Float95.94%
  • Average Daily Volume (1m)3,141,389
  • Average Daily Volume (3m)2,742,499
  • EPS$5.29

Company

  • Revenue$23.74B
  • Rev growth (1yr)-15.64%
  • Net income$818.00M
  • Gross margin58.66%
  • EBITDA margin26.72%
  • EBITDA$1.55B
  • EV$217.11B
  • EV/Revenue9.14
  • P/E45.06
  • P/S7.26
  • P/B3.33